A firm based in Europe has raised a new venture fund of €100 million and is looking to make 4-5 investments over the next 6 to 12 months. The firm could lead any investment up to $15M EUR but will also look for syndicate participation in bigger rounds. Allocations are in the form of equity. Allocations are typically made at the venture stage of development but are open to consider seed through IPO rounds. The firm seeks to invest in any European country and Israel.
The firm will look at a broad spectrum of products and services within the life science space. However, they will not consider drug discovery investments. They will consider anything related to medical devices, diagnostics, in-vitro diagnostics, healthcare IT. They will look at any stage of development within those categories and long as the product or service shows substantial market potential and has proof of concept.
The firm is willing to work with all types of management teams as long as entrepreneurs/founders have a solid knowledge in the industry. A board seat is required for all investments.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org